Skip to content
Screener

Precigen PGEN Short-Term Investments

Short-Term Investments at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$2.35B+134%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.54B+1.2%
Gilead Sciences logo
Gilead SciencesGILD
$0-100%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$236.58M-0.4%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$608.09M+49.6%
Regenxbio logo
RegenxbioRGNX
$69.03M-71.7%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.47B+358%
Enterprise value$2.56B+382%
P/S93.2×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017
(Amounts in thousands, except share data)March 31,2026December 31,2025
Assets
Current assets
Cash and cash equivalents$7,480$30,234
Short-term investments48,76667,624
Receivables
Trade, less allowance for credit losses of $0 as of both March 31, 2026 and December 31, 202526,4033,916
Other302446
Inventory14,7259,581

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's short-term investments?
Precigen (PGEN) reported short-term investments of $48.77M in Q1 2026.
How has Precigen's short-term investments changed year-over-year?
Precigen's short-term investments decreased by 34.3% year-over-year, from $74.18M to $48.77M.
What is the long-term trend for Precigen's short-term investments?
Over 5 years (2020 to 2025), Precigen's short-term investments has grown at a 7.0% compound annual growth rate (CAGR), from $48.33M to $67.62M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Ask your AI about Precigen's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude